Among others, these include BRCA1/2 and Fanconi anemia tumor suppressors, which protect stalled DNA replication forks from degradation by MRE11 and DNA2 nucleases and so suppress genome instability (Schlacher et al., 2011, 2012; Pefani et al., 2014; Higgs et al., 2015; Wang et al., 2015; Ding et al., 2016; Ray Chaudhuri et al., 2016). The gene discussed is BRCA1; the disease is neoplasm.